Mesenchymal stem cells inhibited the differentiation of MDSCs via COX2/PGE2 in experimental sialadenitis
Abstract Background Mesenchymal stem cells (MSCs) can regulate innate and adaptive immune systems through interacting with immune cells directly and secreting multiple soluble factors. Due to their immunosuppressive properties, MSC transplantation has been applied to treat many clinical and experime...
Main Authors: | Jingjing Qi, Xiaojun Tang, Wenchao Li, Weiwei Chen, Genhong Yao, Lingyun Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-07-01
|
Series: | Stem Cell Research & Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13287-020-01837-x |
Similar Items
-
Mesenchymal Stem Cell Enhances the Function of MDSCs in Experimental Sjögren Syndrome
by: Jie Tian, et al.
Published: (2020-12-01) -
Activation of STING by cGAMP Regulates MDSCs to Suppress Tumor Metastasis via Reversing Epithelial-Mesenchymal Transition
by: Hao Cheng, et al.
Published: (2020-06-01) -
Evolution of our understanding of myeloid regulatory cells: from MDSCs to Mregs
by: Masoud H Manjili, et al.
Published: (2014-07-01) -
mTOR inhibitor INK128 promotes wound healing by regulating MDSCs
by: Yi Li, et al.
Published: (2021-03-01) -
Differential diagnosis of bacterial sialadenitis in a rheumatologist's practice: a case report
by: A. V. Torgashina
Published: (2019-03-01)